Abstract:Background: Activating Transcription Factor 4 (ATF4) expression exhibits differential patterns across different types of tumors. Besides, the pathogenesis of breast cancer is complex, and the exact relationship between ATF4 and ATF4 remains uncertain. Methods: The analysis of ATF4 expression was conducted by utilizing The Cancer Genome Atlas (TCGA) pan-cancer data, while the gene expression profile of breast cancer was checked by the comprehensive database-Gene Expression Omnibus database. In order to gain a more comprehensive understanding of the specific cell types that exhibit ATF4 expression within the microenvironment of breast cancer, we conducted a single-cell analysis of ATF4 using two distinct datasets of human breast cancer (GSE114717 and GSE11088, respectively). The spatial distribution of ATF4 within a tissue was demonstrated based on datasets obtained from the Human Protein Atlas (HPA) and SpatialDB. The clinical prognostic significance of ATF4 was assessed by analyzing clinical survival data obtained from TCGA, GSE4830, and GSE25055 datasets. We used the R package clusterProfiler to carry out an enrichment analysis of ATF4. We assessed how ATF4 impacts the growth and movement of breast cancer cell lines. We manipulated ATF4 levels using plasmid transfection techniques. Results: The expression of ATF4 was found to be suboptimal and demonstrated a significant correlation with enhanced disease-specific survival (p = 0.012) and overall survival (p = 0.032) in breast cancer as well as other malignancies. We conducted an analysis to investigate the interaction between the infiltration level of immune cells and the expression of ATF4, using samples obtained from TCGA with known immune cell infiltration scores. Furthermore, a notable positive correlation exists between the elevated expression of ATF4 and immune-related genomes, specifically those associated with chemokine as well as immunity. Subsequent examination revealed a notable augmentation in the cytodifferentiation of T cells into regulatory T (Treg) cells within tissues exhibiting elevated levels of ATF4 expression. ATF4 exhibits notable upregulation in the MDA-MB-231 cell, thereby exerting a substantial impact on cell proliferation and migration upon its knockdown. Conversely, the overexpression of ATF4 in the MCF7 Luminal A breast cancer cell line can also modulate cellular function. Conclusions: Our study suggests that ATF4 helps T cells differentiate into Treg cells in breast cancer. ATF4 can represent a clinically useful biomarker to predict the overall survival rate, especially in patients with different subtypes of breast cancer. Provide certain guidance value for the development of targeted drugs or inhibitors targeting ATF4.

The Oncogenic and Tumor Suppressor Activities of ATF-2

[Dual Role of Transcription Factor AP-2 in Carcinogenesis].

Tumor-Promoting ATAD2 and Its Preclinical Challenges

Activating Transcription Factor 2 Expression Mediates Cell Proliferation and is Associated with Poor Prognosis in Human Non-Small Cell Lung Carcinoma.

Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy

ATF4/NUPR1 Axis Promotes Cancer Cell Survival and Mediates Immunosuppression in Clear Cell Renal Cell Carcinoma

Identification of ATFs in Human Breast Cancer by Integrated Bioinformatic Analysis

Overexpression of Activating Transcription Factor-2 (ATF-2) Activates Wnt/Ca2+ Signaling Pathways and Promotes Proliferation and Invasion in Non-Small-Cell Lung Cancer

Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway

Activating transcription factor 4: a regulator of stress response in human cancers

ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions

A Bioinformatic Analysis Found Low Expression and Clinical Significance of ATF4 in Breast Cancer

Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival

ATF4 in cellular stress, ferroptosis, and cancer

ATF2 Partly Mediated the Expressions of Proliferative Factors and Inhibited Pro-Inflammatory Factors' Secretion in Arsenite-Treated Human Uroepithelial Cells.

Activating transcription factor 4 in malignant tumors and drug resistance

The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis

An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4

ATF1 promotes malignancy of lung adenocarcinoma cells through transcriptionally regulating ZNF143 expression

Rencent Advances in the Function of ATF3

ATF1 Promotes the Malignancy of Lung Adenocarcinoma Cells by Transcriptionally Regulating ZNF143 Expression.